Code |
Diagnosis |
Comment |
Score |
anonymous |
Malignant tumour (100%), suggestive of granulocytic sarcoma. Differential diagnoses -malignant lymphoma, lobular carcinoma
|
Immunostains for myeloperoxidase and c-kit for confirmation of granulocytic sarcoma; LCA, L26 and CD3 to exclude lymphoma and CK to exclude carcinoma
|
100 |
anonymous |
Highly suspicious of carcinoma
|
nil
|
50 |
anonymous |
Granulocytic sarcoma 100%
|
Confirmation with immunostains: Positive with myeloperoxidase, negative for LCA (lymphomas) and cytokeratin (excluding lobular carcinoma).
|
100 |
anonymous |
Hematolymphoid malignancy, favor myeloid leukemia 80%
Infiltrative lobular carcinoma 20%
|
Confirm diagnosis by immunostains: MPO for myeloid leukemia, CD20/CD3 for lymphoma, cytokeratin for lobular carcinoma
|
100 |
anonymous |
GRANULOCYTIC SARCOMA 100%
|
To be confirmed by myeloperoxidase stain.
The differential diagnosis of large cell lymphoma can be excluded by negativity for lymphoma markers. Remote possibility of invasive lobular carcinoma also can be excluded by negative cytokeratin stain.
|
100 |
anonymous |
Malignant infiltration. DDx between hematolymphoid malignancy and infiltrative carcinoma mainly of lobular type. (100%)
|
Do immunostains including myeloperoxidase, CD34 and c-kit (for leukemia); LCA (for lymphoma); and keratin (for carcinoma).
|
100 |
anonymous |
Right breast mass - Granulocytic sarcoma 100%
|
To correlate with blood and bone marrow findings - any AML?
|
100 |
anonymous |
Malignant, consistent with invasive lobular carcinoma (100%) with focal lobular carcinoma in-situ (LCIS) present , to be confirmed by immunostains for epithelial cell marker (CK) and E-cadherin
|
nil
|
50 |
anonymous |
Infiltrative lobular carcinoma 100%
|
nil
|
50 |
anonymous |
General architecture compatible with Infiltrating malignant tumor. Differential diagnosis include Infiltrating lobular carcinoma and Malignant lymphoma.
|
Perform Pancytokeratin and LCA for confirmation.
|
70 |
anonymous |
Invasive lobular carcinoma 100%
|
nil
|
50 |
anonymous |
Haematolymphoid malignancy, probably lymphoma 100%
|
Immunostains: lymphoid CD45, CD20, CD3, CD30
MPO to exclude granulocytic sarcoma
|
100 |
anonymous |
Malignant infiltrate, favor hematolymphoid malignancy, differential diagnoses include pleomorphic lobular carcinoma and angiosarcoma
|
Need immunohistochemistry for definitive diagnosis
|
70 |
anonymous |
Sclerosing lymphocytic lobulitis (diabetic mastopathy)
|
nil
|
0 |
anonymous |
Leukaemic infiltrate, confirmed by CAE and MPO, would exclude lymphoma and lobular carcinoma by immunostaining. 100% Probability
|
nil
|
100 |
anonymous |
Malignant infiltration, favour leukaemic infiltrates (90%), invasive carcinoma (10%)
|
Correlate with clinical history; enzyme stain for CAE ( positive in leukaemic infiltrates) and immunostain for cytokeratin (positive in carcinoma).
|
100 |
anonymous |
Haematolymphoid malignancy. Probably Granulocytic sarcoma.
|
Confirm by myeloperoxidase immunostain. To exclude lymphoma with panel of T and B-cell markers.
|
100 |